NCT00460941
Who may be able to join
Who might be able to join this trial:
- Men, or women who have gone through menopause or have been surgically sterilized, between 18 and 75 years old
- People who have type 2 diabetes and have been taking metformin at a stable dose for at least 3 months
- People whose HbA1c blood sugar level (a measure of average blood sugar over time) was between 7.0% and 9.5% at the initial screening appointment
- People whose weight has stayed roughly the same (within 10% up or down) for at least 3 months before screening
Who may not be able to join:
- People who have type 1 diabetes
- People who have a significant stomach or digestive condition
- People who have taken any diabetes medication other than metformin alone in the last 3 months
- People who have used any weight-loss medications in the last 3 months
- People who have high blood pressure that is not well controlled
- People who have previously used GLP-1 or GLP-1 type medications (a certain class of diabetes treatment) (confirm with trial site if you are unsure whether a medication you have taken falls into this category)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Percentage of patients withdrawn because of gastrointestinal effects
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.